Literature DB >> 15650215

Enhanced cytotoxicity without internuclear spread of adenovirus upon cell fusion by measles virus glycoproteins.

German P Horn1, Sompong Vongpunsawad, Evelyn Kornmann, Barbara Fritz, Dirk P Dittmer, Roberto Cattaneo, Matthias Dobbelstein.   

Abstract

The efficiency of viruses in cancer therapy is enhanced by proteins that mediate the fusion of infected cells with their neighbors. It was reported that replication-competent adenovirus particles can spread between nuclei within fusion-generated syncytia. To assess this conjecture, we generated fusogenic adenoviruses that express a balanced ratio of the F and H glycoproteins of measles virus. The viruses displayed enhanced cytotoxicity but largely unchanged replication efficiencies compared to a nonfusogenic virus. Most notably, the virus genomes did not spread through fusion-generated multinuclear cells. Hence, adenovirus replication in syncytia remains largely restricted to initially transduced nuclei.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650215      PMCID: PMC544120          DOI: 10.1128/JVI.79.3.1911-1917.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.

Authors:  Sompong Vongpunsawad; Numan Oezgun; Werner Braun; Roberto Cattaneo
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 2.  How viruses enter animal cells.

Authors:  Alicia E Smith; Ari Helenius
Journal:  Science       Date:  2004-04-09       Impact factor: 47.728

Review 3.  Adenovirus endocytosis.

Authors:  Oliver Meier; Urs F Greber
Journal:  J Gene Med       Date:  2003-06       Impact factor: 4.565

4.  An oncolytic measles virus engineered to enter cells through the CD20 antigen.

Authors:  Amanda D Bucheit; Shaji Kumar; Deanna M Grote; Yukang Lin; Veronika von Messling; Roberto B Cattaneo; Adele K Fielding
Journal:  Mol Ther       Date:  2003-01       Impact factor: 11.454

Review 5.  Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet.

Authors:  Roberto Cattaneo
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 6.  Replicating adenoviruses in cancer therapy.

Authors:  M Dobbelstein
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

Review 7.  Pigmentary mosaicism in hypomelanosis of Ito. Further evidence for functional disomy of Xp.

Authors:  B Fritz; W Küster; K H Orstavik; A Naumova; J Spranger; H Rehder
Journal:  Hum Genet       Date:  1998-10       Impact factor: 4.132

8.  Antibody-targeted cell fusion.

Authors:  Takafumi Nakamura; Kah-Whye Peng; Sompong Vongpunsawad; Mary Harvey; Hiroyuki Mizuguchi; Takao Hayakawa; Roberto Cattaneo; Stephen J Russell
Journal:  Nat Biotechnol       Date:  2004-02-15       Impact factor: 54.908

9.  Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.

Authors:  A Ahmed; D Jevremovic; K Suzuki; T Kottke; J Thompson; S Emery; K Harrington; A Bateman; R Vile
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

10.  Interaction of p53 with the adenovirus E1B-55 kDa protein.

Authors:  Judith Roth; Matthias Dobbelstein
Journal:  Methods Mol Biol       Date:  2003
View more
  4 in total

1.  Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replication.

Authors:  S Guedan; A Gros; M Cascallo; R Vile; E Mercade; R Alemany
Journal:  Gene Ther       Date:  2008-05-29       Impact factor: 5.250

2.  In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines.

Authors:  Dennis Hoffmann; Wibke Bayer; Oliver Wildner
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 3.  Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic.

Authors:  Joshua Del Papa; Ryan G Clarkin; Robin J Parks
Journal:  Cancer Gene Ther       Date:  2020-07-01       Impact factor: 5.987

Review 4.  Principles of Virus Uncoating: Cues and the Snooker Ball.

Authors:  Yohei Yamauchi; Urs F Greber
Journal:  Traffic       Date:  2016-03-31       Impact factor: 6.215

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.